Injectable Platelet-Rich Fibrin (iPRF)

Home / Scalp & Follicle / Injectable Platelet-Rich Fibrin (iPRF)

Face Architecture Services

Contact Info

LOCATION

Jumeirah 2 Jumeirah Beach Road, Villa 323
P.O. Box 214260, Dubai, UAE

CLINIC HOURS

CONTACT

Injectable Platelet-Rich Fibrin (iPRF)

What Is iPRF Hair Therapy?

Injectable Platelet-Rich Fibrin (iPRF) is an advanced, autologous regenerative treatment that uses the patient’s own blood components to address hair thinning. Processed at a specific low-speed centrifugation velocity, iPRF isolates a concentrated, anticoagulant-free fibrin matrix packed with platelets and leukocytes. Once introduced into the scalp, this biogenic scaffold functions as a slow-release reservoir of essential growth factors that support the hair bulb over an extended period.

The Science | The Sustained Growth Signal

Conventional blood-derived treatments such as standard Platelet-Rich Plasma (PRP) release their growth factors in a single, rapid burst that the body processes within hours. For meaningful, long-term hair shaft thickening and follicular survival, the microenvironment surrounding the hair bulb requires a sustained stimulation signal — not a single dose.

iPRF addresses this directly through its structural composition. Because it is processed without chemical anticoagulants, it forms a natural, three-dimensional fibrin meshwork upon injection. This autologous matrix traps vital platelets and white blood cells, allowing them to slowly release growth factors — including Vascular Endothelial Growth Factor (VEGF) — into the dermal substrate over several days. The result is continuous cellular recruitment and structural support, rather than a brief peak followed by rapid decline.

The Protocol | Autologous Scaffold Delivery

Our clinical approach is designed to maximize the regenerative lifecycle of the blood fractions:

  • Low-Speed Separation: Autologous blood is harvested and processed using a precise, low-G-force centrifugation protocol to preserve cellular integrity and keep white blood cells intact within the sample.
  • Matrix Targeting: The liquid fibrin suspension is delivered immediately via strategic intradermal micro-injections across areas of pattern thinning — before the meshwork cross-links.
  • Prolonged Cascade Induction: The injected matrix solidifies subtly within the tissue, establishing a localized bio-scaffold that drives sustained follicle proliferation and supports hair shaft diameter over time.

Clinical Integration Note: Because iPRF contains zero chemical additives or anticoagulants, it is 100% biocompatible with a virtually non-existent risk of allergic reactions. Its slow-release profile makes it a well-suited finishing phase to sustain the cellular signaling initiated by prior regenerative treatments.

Who Is This For?

This autologous regenerative protocol is suited to individuals seeking structural hair shaft thickening and a sustained growth stimulus without chemical additives. It is indicated for:

  • Early to Mid-Stage Androgenetic Alopecia: Patients with diffuse thinning, a widening part, or a receding hairline who still possess viable, miniaturized hair follicles.
  • Post-Shedding Recovery (Telogen Effluvium): Individuals looking to stabilize acute hair fall and support density recovery following stress, metabolic shifts, or illness.
  • Biocompatibility-Focused Patients: Those seeking a 100% natural, drug-free approach to hair restoration, or who have sensitive scalps prone to reactions from synthetic compounds.
  • Combination Protocol Maintenance: Patients seeking a finishing-phase treatment to anchor and prolong the cellular signaling initiated by prior exosome or polynucleotide therapies.

Frequently Asked Questions.

What is the difference between PRP and iPRF for hair thinning?
The primary distinction lies in the delivery speed of growth factors and the presence of a structural matrix. Standard PRP releases its growth factors rapidly and contains no fibrin scaffolding. iPRF is processed at a lower centrifugation speed, retaining a high concentration of leukocytes and platelets within a natural fibrin mesh. This allows for a controlled, sustained release of growth factors over several days — making it notably more effective for improving structural hair density over time.
Initial signs of stabilization — such as a noticeable reduction in daily hair shedding — are typically observed within 6 to 8 weeks. For visible changes in hair shaft diameter and macroscopic density, a clinical series of 3 to 4 sessions spaced 4 weeks apart is recommended. This allows the autologous biogenic matrix to progressively optimize the follicular ecosystem with each cycle.

Book an appointment

If you would like to schedule an appointment or a free consultation, please leave your info and we will contact you as soon as possible.

PREMIUM AESTHETIC CLINIC • DUBAI • MIDRIF •